BNTC
Price
$12.58
Change
+$0.93 (+7.98%)
Updated
Dec 3 closing price
Capitalization
427.34M
Intraday BUY SELL Signals
RXRX
Price
$4.66
Change
+$0.34 (+7.87%)
Updated
Dec 3 closing price
Capitalization
2.43B
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BNTC vs RXRX

Header iconBNTC vs RXRX Comparison
Open Charts BNTC vs RXRXBanner chart's image
Benitec Biopharma
Price$12.58
Change+$0.93 (+7.98%)
Volume$816.86K
Capitalization427.34M
Recursion Pharmaceuticals
Price$4.66
Change+$0.34 (+7.87%)
Volume$19.82M
Capitalization2.43B
BNTC vs RXRX Comparison Chart in %
View a ticker or compare two or three
VS
BNTC vs. RXRX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTC is a StrongBuy and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (BNTC: $11.65 vs. RXRX: $4.33)
Brand notoriety: BNTC and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTC: 45% vs. RXRX: 20%
Market capitalization -- BNTC: $427.34M vs. RXRX: $2.43B
BNTC [@Biotechnology] is valued at $427.34M. RXRX’s [@Biotechnology] market capitalization is $2.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTC’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • BNTC’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than BNTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTC’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • BNTC’s TA Score: 5 bullish, 5 bearish.
  • RXRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BNTC and RXRX are a good buy in the short-term.

Price Growth

BNTC (@Biotechnology) experienced а -9.86% price change this week, while RXRX (@Biotechnology) price change was -0.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

RXRX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.43B) has a higher market cap than BNTC($427M). BNTC YTD gains are higher at: -7.720 vs. RXRX (-35.947). BNTC has higher annual earnings (EBITDA): -29.77M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. BNTC (104M). BNTC has less debt than RXRX: BNTC (959K) vs RXRX (88.1M). RXRX has higher revenues than BNTC: RXRX (64.5M) vs BNTC (0).
BNTCRXRXBNTC / RXRX
Capitalization427M2.43B18%
EBITDA-29.77M-583.64M5%
Gain YTD-7.720-35.94721%
P/E RatioN/AN/A-
Revenue064.5M-
Total Cash104M525M20%
Total Debt959K88.1M1%
FUNDAMENTALS RATINGS
BNTC: Fundamental Ratings
BNTC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNTCRXRX
RSI
ODDS (%)
Bullish Trend 7 days ago
89%
Bullish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
88%
Bearish Trend 7 days ago
90%
Momentum
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
86%
MACD
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
86%
Bullish Trend 7 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
86%
Advances
ODDS (%)
Bullish Trend 14 days ago
86%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 15 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 7 days ago
79%
Aroon
ODDS (%)
Bullish Trend 7 days ago
90%
Bearish Trend 7 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BNTC
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFCMX19.07N/A
N/A
American Century Focused Intl Gr R6
PETGX14.11N/A
N/A
Gabelli Pet Parents'™ A
FIVVX39.02N/A
N/A
Nomura Opportunity R6
TAMMX37.82N/A
N/A
Transamerica Multi-Managed Balanced R6
FIQWX18.43N/A
N/A
Fidelity Advisor Strategic Div & Inc Z

BNTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTC has been loosely correlated with TNGX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTC jumps, then TNGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTC
1D Price
Change %
BNTC100%
-4.70%
TNGX - BNTC
36%
Loosely correlated
-3.17%
XERS - BNTC
33%
Poorly correlated
-7.04%
IKT - BNTC
32%
Poorly correlated
-6.00%
RXRX - BNTC
31%
Poorly correlated
-0.69%
MLTX - BNTC
30%
Poorly correlated
-5.36%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-0.69%
CRSP - RXRX
68%
Closely correlated
-1.13%
ABSI - RXRX
63%
Loosely correlated
+0.16%
BEAM - RXRX
61%
Loosely correlated
-2.83%
ABCL - RXRX
59%
Loosely correlated
N/A
RGNX - RXRX
54%
Loosely correlated
-3.10%
More